| Synonyms: | |
| Status: | Approved (1997) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N04BC04 |
| UNII: | 030PYR8953 |
| InChI Key | UHSKFQJFRQCDBE-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H24N2O |
| Molecular Weight | 260.38 |
| AlogP | 2.85 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 32.34 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 19.0 |
| Primary Target | |
|---|---|
| D2 receptor | |
| D3 receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Dopamine receptor
|
30-330 | 56-985 | - | 3-61 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
- | - | - | 1706 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Parkinson Disease | 4 | D010300 | ClinicalTrials |
| Restless Legs Syndrome | 3 | D012148 | ClinicalTrials |
| Stroke | 2 | D020521 | ClinicalTrials |
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Fibromyalgia | 2 | D005356 | ClinicalTrials |
| Hyperprolactinemia | 1 | D006966 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 91374-21-9 |
| ChEBI | 8888 |
| ChEMBL | CHEMBL589 |
| DrugBank | DB00268 |
| DrugCentral | 2402 |
| EPA CompTox | DTXSID8045195 |
| FDA SRS | 030PYR8953 |
| Human Metabolome Database | HMDB0014413 |
| Guide to Pharmacology | 7295 |
| KEGG | C07564 |
| PharmGKB | PA164749035 |
| PubChem | 5095 |
| SureChEMBL | SCHEMBL35212 |
| ZINC | ZINC000000002041 |